Immix Biopharma
(NASDAQ) IMMX
Immix Biopharma Financials at a Glance
Market Cap
$490.45M
Revenue (TTM)
$0.00
Net Income (TTM)
$29.44M
EPS (TTM)
$-0.89
P/E Ratio
-10.40
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$9.27
Volume
399,472.347
Open
$9.78
Price
$9.27
Volume
399,472.347
Open
$9.78
Previous Close
$9.26
Daily Range
$9.12 - $9.96
52-Week Range
$1.56 - $11.61
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$9.27
Volume
399,472.347
Open
$9.78
Previous Close
$9.26
Daily Range
$9.12 - $9.96
52-Week Range
$1.56 - $11.61
IMMX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Immix Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
21
CEO
Ilya Rachman, MD, PhD
Website
www.immixbio.comHeadquarters
Los Angeles, CA 90064, US
IMMX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-55%
Return on Capital
-32%
Return on Assets
-28%
Earnings Yield
-9.62%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$490.45M
Shares Outstanding
52.96M
Volume
399.47K
Short Interest
0.00%
Avg. Volume
849.35K
Financials (TTM)
Gross Profit
$364.50K
Operating Income
$27.21M
EBITDA
$26.85M
Operating Cash Flow
$23.93M
Capital Expenditure
$732.92K
Free Cash Flow
$24.66M
Cash & ST Invst.
$100.41M
Total Debt
$1.07M
Immix Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$90.63K
N/A
Gross Margin
0.00%
N/A
Market Cap
$490.45M
N/A
Market Cap/Employee
$27.25M
N/A
Employees
18
N/A
Net Income
$10.69M
-122.1%
EBITDA
$10.80M
-118.4%
Quarterly Fundamentals
Net Cash
$99.34M
+498.2%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$933.63K
-7.5%
Short Term Debt
$139.34K
+113.6%
Return on Assets
-28.08%
N/A
Return on Invested Capital
-31.62%
N/A
Free Cash Flow
$11.19M
-464.4%
Operating Cash Flow
$11.03M
-647.2%